Stuart Barlow

Mr. Barlow brings more than 40 years in accounting and financial management, including 13 years in drug development. He concurrently serves as chief accounting officer for Auven Therapeutics, a life sciences private equity firm. Mr. Barlow is a certified public accountant. He received his undergraduate degree from Boston University and an MBA degree from Columbia University.